Table 3 Tumor stage distribution by chronological year, 2000–2012
Year | I | II | III | IV | Unknown | Total |
|---|---|---|---|---|---|---|
2000 | 104 (30.6%) | 144 (42.4%) | 54 (15.6%) | 22 (6.5%) | 17 (5.0%) | 341 |
2001 | 102 (29.7%) | 152 (44.3%) | 64 (18.7%) | 15 (4.4%) | 10 (2.9%) | 343 |
2002 | 111 (28.0%) | 173 (43.6%) | 71 (17.9%) | 24 (6.0%) | 18 (4.5%) | 397 |
2003 | 94 (28.8%) | 125 (38.4%) | 70 (21.7%) | 18 (5.6%) | 18 (5.6%) | 325 |
2004 | 115 (33.7%) | 137 (39.9%) | 62 (17.8%) | 17 (4.4%) | 14 (4.1%) | 345 |
2005 | 119 (34.7%) | 134 (39.1%) | 57 (16.6%) | 23 (6.7%) | 10 (2.9%) | 343 |
2006 | 127 (32.6%) | 148 (38.0%) | 87 (22.4%) | 14 (3.6%) | 13 (3.3%) | 389 |
2007 | 133 (32.4%) | 155 (37.8%) | 85 (20.7%) | 20 (4.9%) | 17 (4.1%) | 410 |
2008 | 154 (36.9%) | 165 (39.8%) | 70 (16.9%) | 13 (3.1%) | 14 (3.4%) | 416 |
2009 | 204 (41.5%) | 192 (39.1%) | 69 (13.9%) | 16 (3.1%) | 12 (2.5%) | 493 |
2010 | 174 (41.8%) | 134 (32.2%) | 70 (16.9%) | 18 (4.5%) | 19 (4.5%) | 415 |
2011 | 175 (37.8%) | 168 (36.6%) | 77 (17.0%) | 31 (6.9%) | 8 (1.7%) | 459 |
2012 | 180 (40.5%) | 171 (38.3%) | 75 (16.9%) | 12 (2.9%) | 6 (1.3%) | 444 |
Overall | 1792 (35.0%) | 1998 (39.0%) | 911 (17.8%) | 243 (4.8%) | 176 (3.4%) | 5120 |